POY_1170x120_8-12-19

average manufacturer price

Rx takes hard look at long-awaited Medicaid AMP rule

Rx takes hard look at long-awaited Medicaid AMP rule

ARLINGTON, Va. — The National Association of Chain Drug Stores was working with member companies at presstime to review the final rule on Medicaid prescription reimbursements. The Centers for Medicare & Medicaid Services (CMS) says the 658-page rule — which takes effect April 1 after a comment period — establishes a regulatory definition for average

Industry eyes CMS final rule for Rx reimbursement

Industry eyes CMS final rule for Rx reimbursement

WASHINGTON — The Centers for Medicare & Medicaid Services (CMS) has issued the Covered Outpatient Drugs final rule with comment, which the National Association of Chain Drug Stores said includes “significant changes” to Medicaid pharmacy reimbursement for generic drugs based on the average manufacturer price (AMP) model. Released on Thursday and due to be published

Lawmakers back transition period for AMP-based FULs

ARLINGTON, Va. — The National Association of Chain Drug Stores has applauded the efforts of several members of Congress to obtain a transition period for new federal upper limits (FULs) in Medicaid reimbursement. NACDS said Monday that in letters sent late last week, 64 members of the Senate and the House of Representatives urged Health